US FDA Approved Glenmark’s Nicardipine Hydrochloride Capsules
The US Food and Drug Administration (FDA) has approved Glenmark Pharmaceuticals’ Nicardipine Hydrochloride Capsules, 20 mg and 30 mg, the generic version of Cardene Capsules, of Chiesi USA, Inc. The company’s Nicardipine Hydrochloride Capsules will be distributed in the United States by Glenmark Pharmaceuticals Inc., USA. According to IQVIA sales data, the Cardene Capsules market […]
Continue Reading